The limitations of immunosuppressant therapy in Multiple Sclerosis.
Sedal
L
L
Department of Clinical Neuroscience and Neuroimmunology Clinic, St Vincent's Hospital, Victoria, Australia.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008727:Methotrexate / Q000627:therapeutic use; D008942:Mitoxantrone / Q000627:therapeutic use; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000523:psychology
D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D008942:Mitoxantrone; D008727:Methotrexate